Guided Therapeutics, Inc. (GTHP)

Market Cap	8.38M
Revenue (ttm)	104,000
Net Income (ttm)	2.19M
Shares Out	13.30M
EPS (ttm)	0.02
PE Ratio	42.00
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,512
Open	0.600
Previous Close	0.640
Day's Range	0.590 - 0.640
52-Week Range	0.085 - 1.000
Beta	0.84
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About GTHP

Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was incorporated in 199...

• Industry: Medical Devices
• IPO Date: Jul 1, 1997
• CEO: Mark Faupel
• Employees: 6
• Stock Exchange: OTCMKTS
• Ticker Symbol: GTHP

Full Company Profile

News

There is no news available yet.